Analysis of M&A in the Indian Pharma and their Stock Price
| Vol-3 | Issue-12 | December 2018 | Published Online: 10 December 2018 PDF ( 459 KB ) | ||
| Author(s) | ||
| Lakshit Chopra 1; Madhav Kejriwal 2 | ||
|
1B.Com F&A, Department of Professional Studies, Christ University, Karnataka (India) 2B.Com F&A, Department of Professional Studies, Christ University, Karnataka (India) |
||
| Abstract | ||
This paper is to examine the impact that the announcement of a merger and acquisition on the stock prices of such company. The focus of this paper has been narrowed down to companies in the Indian Pharmaceutical Industry. This paper focuses upon 3 key deals; Sunpharma and Ranbaxy, Unichem and Torrent and Piramal and Abbot. To conduct this study, the Market study model was used taking a 61 day time period; 30 days before and 30 days after the announcement of such merger and acquisition. |
||
| Keywords | ||
| Merger and Acquisition, Market Study Model, Stock Prices, Pharmaceutical Companies | ||
|
Statistics
Article View: 509
|
||
